Answer
Women of reproductive potential are advised to use effective contraception during pentostatin treatment and for at least 6 months after their last dose because of potential genotoxicity and teratogenicity.
Sources for this answer
- Nipent 10 mg powder for solution for injection, powder for solution for infusionHospira UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 10Document updated
Sources checked